The US FDA has approved two treatments developed by Israel’s Teva, for adolescents and adults with asthma. They are AirDuo RespiClick (fluticasone propionate and salmeterol inhalation powder) and ArmonAir RespiClick (fluticasone propionate inhalation powder).

http://www.globes.co.il/en/article-fda-approves-two-teva-asthma-treatments-1001174386